Freenome

Freenome is an early cancer detection company developing blood-based tests to detect cancer when it is most treatable. 

Domain
Healthcare
Status
IPO’d/​Acquired
IPO Date
2026
Stage of Initial Investment
Series B
Initial Investment Year
2019
Freenome Hover Image